Table 3 Types of AE experienced by the participants during the trial.

From: Oleoylethanolamide supplementation improves mood and reduces fatigue in veterans with GWI in a 15-week randomized, double-blind, placebo-controlled exploratory clinical trial

Number of participants (%)

Placebo (n = 26)

OEA (n = 26)

Abnormal labs

1 (2.6)

2 (5.7)

Cognitive

2 (5.1)

0 (0.0)

Cold/flu/COVID19

4 (10.3)

1 (2.9)

Fatigue

1 (2.3)

2 (5.4)

Gastrointestinal

11 (25.6)

12 (32.4)

Genitourinary

3 (7.0)

0 (0.0)

Musculoskeletal

5 (11.68)

3 (8.1)

Neurological

1 (2.3)

2 (5.4)

Psycho-affective

2 (4.7)

3 (8.1)

Other

12 (27.9)

10 (27.0)

Sleep

1 (2.3)

2 (5.1)

Total

43 (100%)

37 (100)

Back to article page